A sample report on
Australia Patient
Support Program
Market Analysis
Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2021 – 2030F) www.insights10.com
This report presents a strategic analysis of the Australia Patient Support Program market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, characteristics, main players, trends and insights, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Australia Patient Support Program market, and offers unmatched value, accuracy, and expert insights
• Market Overview
• Growth Drivers & Restraints
• Market Segmentation
Table of
• Major Market Share
• Competitive Landscape
Contents
• Key Company Profiles
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth
• Future Opportunities
• Conclusion
Table of Contents
1. Australia Patient Support Program Market Overview………………..……….……………………………....................................6
1.1 Market size and forecast
1.2 Patient support programs: What do they offer?
2. Market Growth Drivers and Restraints …………………………………………………………………….…………….…………….9
2.1 Market Growth Drivers
2.1.1 Rising number of collaborations and partnerships between stakeholders 2.1.2 Increasing adoption of digital therapeutics and remote monitoring solutions 2.1.3 Implementation of government regulations and initiatives to promote patient-centric care 2.2 Market Restraints
2.2.1 Patient needs are unique and vary by region 2.2.2 Formulary restrictions and cost-sharing
3. Market Segmentation……………………………………………………………….…………………..…………………..………….….15
3.1 By caregiver access
3.2 By healthcare financing
4
A Sample Report on Australia Patient Support Program Market I Confidential
Table of Contents (continued)
4. Major Products Market Share………………………..…………………………………………………………………..…………....…19
4.1 Market analysis, insights and forecast - By revenue
5. Competitive Landscape……………………………………………………..……………………...…………..…................................21
5.1 Major companies for Australia market
6.1 AstraZeneca
6.2 GSK
6.3 Abbvie
6.4 Vaitris
7. Healthcare Policies and Regulatory Landscape…………………………………………………….……………………..………....28
7.1 Regulatory framework of Australia patient support program market
8. Factors Driving Future Growth………………………………………………………………………………………………..………....30
8.1 Recent developments in patient support program
9. Future Opportunities…………………..…………..………………………………….………………………………………………......32
9.1 Future Opportunities
10. Conclusion……………………………..…………..………………………………….………………………………………………......34
5
A Sample Report on Australia Patient Support Program Market I Confidential
Australia Patient Support Program Market Analysis 1. Overview
1.1 Market size & forecast
Key Analysis
Australia Patient Program Market Forecast (2022-2030F)
▪
Australia Patient Support Program (PSP) stood at around USD XX Bn in 2021 and is projected to reach USD XX Bn $ XX
by 2030, exhibiting a CAGR of XX % during the forecast period
▪
Pharmaceutical companies play a key role in supporting the quality use of medicines through patient focused programs. These programs are designed to aid compliance and lifestyle choices
$ XX
▪
PSPs provide significant value to patients through the accessibility of information and support and the participation is only available to patients who have been already prescribed a medicine and supported by their healthcare professional
SAMPLE
7
A Sample Report on Australia Patient Support Program Market I Confidential
1.2 Patient support programs: What do they offer?
Patient Support Programs (PSPs)
Patient Access Programs
Patient Adherence Programs
Convenience Programs
Financial
Named Patient
Patient Education
Other Support
Assistance
Loyalty Programs
Programs (NPP)
Programs
Programs
Programs
8
A Sample Report on Australia Patient Support Program Market I Confidential
Australia Patient Support Program Market Analysis 2. Growth Drivers & Restraints
Market growth drivers and restraints
Drivers
Rising number of
Increasing adoption of
Implementation of
collaborations and
digital therapeutics and
government regulations
partnerships between
remote monitoring
and initiatives to promote
stakeholders
solutions
patient-centric care
Restraints
Patient needs are unique
Formulary restrictions and
and vary by region
cost-sharing
10
A Sample Report on Australia Patient Support Program Market I Confidential
2.1 Market growth drivers
2.1.1 Rising number of collaborations and partnerships between stakeholders
▪
As many patient organizations work with pharma industry on various different levels – from knowledge sharing to financial support – it is key to shape those relationships in a transparent way 11
A Sample Report on Australia Patient Support Program Market I Confidential
Market growth drivers (continued)
2.1.2 Increasing adoption of digital therapeutics and patient engagement solutions
▪
Increasing trend of delivering patient engagement experiences across digital marketing channels to interact with patients, helping them stay engaged with their health
▪
Increasing use of digital technology in the patient support program helps patient and the care giver to track the health condition including the proper guidance to patient whenever and wherever required 12
A Sample Report on Australia Patient Support Program Market I Confidential
Market growth drivers (continued)
2.1.3 Implementation of government regulations and initiatives to promote patient-centric care
▪
Favorable government initiatives are likely to impact market growth in the coming years. The Australian government has clearly defined the patient support programs having an objective of the healthcare and wellbeing of the patients including the emotional as well as the financial support 13
A Sample Report on Australia Patient Support Program Market I Confidential
2.2 Market restraints
2.2.1 Patient needs are unique and vary by 2.2.2 Formulary restrictions and cost-regions
sharing
▪
There is opportunity to leverage learnings, but
▪
More than half faced a formulary restriction, and there’s no plug-and-play method when it comes some abandoned due to cost
to PSPs
▪
For launch and mature brands alike, that access
▪
What is successful for one product in one region, increasingly comes with higher patient cost-will struggle to be directly lifted into a new region sharing and utilization restrictions such as prior namely because across countries and regions
authorization and step therapy
the patient journey will differ
14
A Sample Report on Australia Patient Support Program Market I Confidential
Australia Patient Support Program Market Analysis 3. Market Segmentation
Australia patient support program market segmentation Patient Support Program Market Segmentation Caregiver Access
Healthcare Financing
Virtual Care/ Telehealth
Benefit Coverage (BI/PA/Appeal)
Remote Monitoring
Co-pay assistance
Healthcare at Home
Alternative Coverage / PAPs
Patient Transportation
Reimbursement Support
Health Coaching
16
A Sample Report on Australia Patient Support Program Market I Confidential
3.1 Market segmentation: By caregiver access Patient Support Program Market Share by Caregiver Access Key Insights
(2021)
▪
Remote patient monitoring enables monitoring of patients outside conventional clinical settings thereby increasing access to care and reducing healthcare delivery costs
▪
Home healthcare is a supportive care provided by medical professionals at patient’s home for the purpose of promoting, maintaining or restoring health or maximizing the level of independence while minimizing the effects of disability and illness
Virtual Care/
Remote
Healthcare at
Patient
Health
Telehealth
Monitoring
Home
Transportation
Coaching
17
A Sample Report on Australia Patient Support Program Market I Confidential
3.2 Market segmentation: By healthcare financing Patient Support Program Market Share by Healthcare Financing Key Insights
(2021)
▪
Electronic Prior Authorization (ePA)- it is the electronic transmission of information between the prescriber, and payer to determine whether or not the PA is granted
▪
Reimbursement Support - Services remove barriers to successful payment of claims and provide a resource for patients with coverage-related questions
Benefit Coverage
Co-pay Assistance
Alternative
Reimbursement
(BI/PA/Appeal)
Coverage / PAPs
Support
18
A Sample Report on Australia Patient Support Program Market I Confidential
Australia Patient Support Program Market Analysis 4. Major Market Share
4.1 Major patient support program operators Key Insights
▪
From the pharmaceutical company’s perspective, PSPs contribute to better patient outcomes overall, and as the industry shifts more toward outcomes-based payment models, enhancing actual patient outcomes will be a crucial success element
▪
A strong patient support program will influence the approval of treatments and market authorizations and will boost patient enrollment
20
A Sample Report on Australia Patient Support Program Market I Confidential
Australia Patient Support Program Market Analysis 5. Competitive Landscape
5.1 Major players revenue (current and forecast) Major Market Revenue of Patient Support Services Companies ($Bn)
Key Insights
SAMPLE
AstraZeneca
GSK
Abbvie
Viatris
Revenue share used for PSP
Other revenue
22
A Sample Report on Australia Patient Support Program Market I Confidential
Australia Patient Support Program Market Analysis 6. Key Company Profiles
6.1 AstraZeneca
Company Overview
Company at a Glance
• The AstraZeneca Patient Support Programs help patients Company Name: AstraZeneca
navigate the complexities of reimbursement and provide support during the journey of their treatment
• Connect360, AstraZeneca Oncology patient support programs Year of Establishment: 1999
are some of the PSPs going on currently
Headquarter: Cambridge, US
Revenue (EU): $37.4 Bn (2021)
Website: www.astrazeneca.com
24
A Sample Report on Australia Patient Support Program Market I Confidential
6.2 GSK
Company Overview
Company at a Glance
• GSK has patient support program named NuYou Support that is Company Name: GSK
being offered to the Australian patients
• GSK provides the access to its Asthma drugs Nucala and the access to helpful resources for treatment in Australia Year of Establishment: 2000
Headquarter: Brentford, UK
Revenue (EU): $33.3 Bn (2021)
Website: www.gsk.com/en-gb/
25
A Sample Report on Australia Patient Support Program Market I Confidential
6.3 Abbvie
Company Overview
Company at a Glance
• In Australia Abbvie have created patient support programs that Company Name: Abbvie
currently benefit more than 14,000 patient lives and help support them for better health outcomes
• AbbVie’s patient support and services go far beyond basic Year of Establishment: 2013
disease information with support programs that enable them to remain as active and independent as possible and ensure optimal care
Headquarter: Illinois, US
Revenue (EU): $14.8Bn (2021)
Website: www.abbvie.com/
26
A Sample Report on Australia Patient Support Program Market I Confidential
6.4 Viatris
Company Overview
Company at a Glance
•
Viatris has MyEpiPen® Patient Support Program for Australian Company Name: Viatris
patients. Australia’s 35,000-member EpiClub® program has been revamped and rebranded by Viatris (formerly Mylan) as the MyEpiPen® Patient Support Program
Year of Establishment: 1961
Headquarter: Pennslyvania, US
Revenue (EU): $11.9 Bn (2021)
Website: www.viatris.com
27
A Sample Report on Australia Patient Support Program Market I Confidential
Australia Patient Support Program Market Analysis 7. Healthcare Policy and Regulatory Landscape
7.1 Regulatory framework of Australia patient support program market
▪ The Department of Health in Australia has defined as - The healthcare and wellbeing of patients must be the only objective of a Patient Support Program
▪ Rules and key pointers:
▪ Any payments should be included in the company’s reporting of financial support, grants etc. in the interests of being open and transparent about the conduct and management of a PSP
▪ In relation to data that is collected in a Patient Support Program, the Department suggests there should be further clarification of the types of information that can be communicated to healthcare professionals 29
A Sample Report on Australia Patient Support Program Market I Confidential
Australia Patient Support Program Market Analysis 8. Factors Driving Future Growth
8.1 Recent developments in patient support program
▪
Pharma manufacturers often use training materials to create awareness for these programs, a channel growing in popularity is actively participating in the patient journey — more specifically, connectivity with electronic health records (EHRs) systems to augment education. These integrations builds improved awareness for providers, growing program adoption
▪
As more specialty products come to the market, compressing onboarding time through technology solutions for both prior authorizations and electronic benefits investigations will ensure patients get on (and stay on) therapies 31
A Sample Report on Australia Patient Support Program Market I Confidential
Australia Patient Support Program Market Analysis 9. Future Opportunities
9.1 Future Opportunities
▪
AI, machine learning and natural language processing tools can identify both clinical and socioeconomic data points to ensure patient support teams are spending time with the right patients, particularly with those who may be closer to nonadherence
33
A Sample Report on Australia Patient Support Program Market I Confidential
Australia Patient Support Program Market Analysis 10. Conclusion
10.1 Conclusion
Growing Technology
Advancements
With the emerging technology
and the transformation from
paper to digital, companies are
offering virtual care to patients
Emerging Initiative
and HCPs
Increasing pressure on the
Support for the HCPs
pharma companies to help
Patient support programs are
patients with the access of their
also assisting HCPs to deliver
drugs is done through various
healthcare virtually with the
initiatives
comfort of being at their home
during COVID-19 pandemic
3
2
4
Strong Demand
Advancement in healthcare
With the implementation of
delivery
government norms towards
PSPs would enhance the way
patient centricity there is an
healthcare was delivered to the
increase demand
patient earlier, with new
innovations coming up that will
1
5
help to reduce the overall cost
of treatment
35
A Sample Report on Australia Patient Support Program Market I Confidential
Methodology & Scope
Research Methodology
▪
Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions
▪
We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources
▪
For forecasting, the following parameters are considered:
❑
Market drivers and restraints along with their current and expected impacts
❑
Technological scenario and expected developments
❑
End use industry trends and dynamics
❑
Trends in the consumer behavior
❑
Regulatory scenario and expected developments
❑
Current capacity and expected capacity additions up to 2030
▪
We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate
▪
We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions
▪
All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪
Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn) 37
A Sample Report on Australia Patient Support Program Market Analysis I Confidential
Analysis Methodology
Our Analysis Methodology involves three critical stages: Market Data Analysis
Interpretation &
Data Collection
& Statistical Model
Presentation
Analysis &
Market Trends
Interpretation
Secondary
Research
Market Sizing &
Insights
Analysis
Primary
Research
Data Triangulation &
Presentation &
Validation
Reporting
38
A Sample Report on Australia Patient Support Program Market Analysis I Confidential
Data Triangulation & Data Validation
Top Down Approach
Final
Final Market size break up to
Market
rest of segmentation
Size
Validation from
Arriving at market size
Primary Interview
of each segment
Summarization of revenue
generated from companies
Validation from
to arrive at total market size
Primary Interview
Revenue generated by products &
Final
services offered by companies
Summary
Bottom Up Approach
39
A Sample Report on Australia Patient Support Program Market Analysis I Confidential
Key Benefits for Stakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors 40
A Sample Report on Australia Patient Support Program Market Analysis I Confidential
Time Frame
Report Attribute
Details
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn)
Base Year for
2021
Estimation
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Report Coverage
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is Customized Report
currently not a part of our scope as a part of 2022-Forecast
customization
2030
Period
Pricing and purchase
Avail customized purchase options to meet
options
your exact research needs
What kind of Data is Presented
in this Report?
This report presents data, which is:
Reliable
Expert-verified
Real
Comprehensive
Easy to read
The report is prepared
The data is prepared by
Allowing you to
Covers everything you
You do not have to be a
using a proven
a team of highly qualified
confidently make
would need to know
market expert to
methodology and
& experienced research
smarter business
about the market
understand what really is
insightful research
analysts & vetted by our
and strategic
including market size,
happening on the market
local associates
decisions
competitive analysis &
and how it works
much more
www.insights10.com
About
Lifesciences Market
Research Reports you
can trust
A large database of over 30,000 syndicated market research reports in pharmaceuticals and
healthcare sector at global, regional as well as country level. We also provide customized
research reports tailor made to suit your needs
Get Insights to take
informed Business
Decisions
Insights10 is a healthcare focused market
research firm founded with an aim of being an insights driven company in the data driven world and delivering actionable insights that can drive decision and strategy making process for
businesses
Market Research Reports
across various domains of healthcare
Pharmaceuticals
Digital
Medical
Healthcare
OTC &
Clinical
(Diseases & Drugs) Health
Devices
Services
Nutraceuticals
Trials
Market Research Reports
1
6
Full-Time Engagement
Customized Reports
2
7
Conference Coverage
Our
Primary Research
3
Services
8
Competitive Intelligence
Strategic Research Projects
4
9
Regulatory Compliance
Database Services
5
10
Report Subscription Services
Our Research Process
01
02
03
04
05
Identification of
Market
Collection of
Collaboration
Verification &
Data
Dynamics
Data
of Data
Analysis
Statistical Databases
Company Websites/Annual Reports
Data
Sources
Trade Publications
We have access to multiple highly
Online Databases
reliable free and subscription data
sources. We have many years of
experience to understand which
Published Research Reports
sources are more dependable for what
and which to prefer for the reliable and
Whitepapers
latest information.
Press Releases of Key Market Players
Over the years, we have developed an in-depth experience of executing market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions
Research Projects Done
Project Leadership Team
Dr. Purav Gandhi
Mukesh Nayak
Ritu Baliya
Dhruv Joshi
Founder & CEO
Head - Marketing
Engagement Manager
Consultant
Purav is a physician and an
Mukesh is an engineering graduate
Ritu has over 6 years of experience in
Dhruv Joshi is an engineer and has done
entrepreneur with 12+ years of
with an MBA in Marketing. He is a
strategy building, market assessments,
Masters in Hospital Administration with
experience in Healthcare & Life
seasoned healthcare market
market sizing, and RWE for global MNC
over 4 years of experience in the
Sciences industry spanning across
research & marketing professional
healthcare & biopharma clients across
healthcare and life science industry. He
strategy, market access, health
with a progressive experience of over
diff. markets (America, Europe, Africa,
has gained proficiency in market
informatics and RWE, digital health,
20 years in Life Sciences, Pharma
APAC and Middle East). Her areas of
research, market assessment, and
analytics and data science. Purav
and Medical Device sectors . With an
expertise include: Indentifying emerging
developing insights from it. He has
studied medicine from Gujarat
in-depth understanding of primary
trends in life sciences industry,
worked on various consulting projects
University and also completed his MBA
research, he has conducted
Competitor landscape assessment,
across different geographies including
from IIM-Kozhikode. Purav started his
hundreds of interviews of various
Disease opportunity assessments etc.
Asia, Europe, US, MENA. He has been
career with Deloitte working on strategy
stakeholders in pharma & healthcare
She is a pro in secondary and primary
aligned in working for sector reports of
consulting engagements and also co-
& completed several research
research with a deep domain expertise
various geographies along with market
founded ConvergeHealth by Deloitte.
projects across life sciences industry.
in healthcare sector.
sizing and forecasting.
7 years of experience working with leading organizations in pharma, MedTech and healthcare domain. Some of our recent clients are mentioned below
… and many more
We would be happy to help.
Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
Whatsapp: (+91) 931 639 7935
Reads:
3
Pages:
42
Published:
Apr 2024
"Universal Principles" is a thought-provoking guide by Ogu Babafemi Okechukwu that delves into timeless truths transcending cultural boundaries. Through relat...
Formats: PDF, Epub, Kindle, TXT
Reads:
14
Pages:
59
Published:
Jan 2024
Everything You Ever Wanted To Know About Infinite Banking
Formats: PDF, Epub, Kindle, TXT
Reads:
4
Pages:
61
Published:
Jan 2024
By 2030, it is anticipated that the Japan Radiotherapy Market will reach a value of $711 Mn from $430 Mn in 2022, growing at a CAGR of 6.5% during 2022-30. Th...
Formats: PDF, Epub, Kindle, TXT
Reads:
4
Pages:
27
Published:
Oct 2023
The global breast cancer therapeutics market is poised for substantial expansion, forecasted to increase from $18.2 Bn in 2022 to an impressive $48.0 Bn by 20...
Formats: PDF, Epub, Kindle, TXT
